Adult-derived stem cells from the liver become myocytes in the heart in vivo.
about
Phosphatidylcholine Specific PLC-Induced Dysregulation of Gap Junctions, a Robust Cellular Response to Environmental Toxicants, and Prevention by Resveratrol in a Rat Liver Cell ModelCardiac muscle plasticity in adult and embryo by heart-derived progenitor cells.The new stem cell biology: something for everyone.In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cellsThe role of stem cells in skeletal and cardiac muscle repair.Calcium dependent CAMTA1 in adult stem cell commitment to a myocardial lineageStem cell treatment of the heart: a review of its current status on the brink of clinical experimentationTumor promoting properties of a cigarette smoke prevalent polycyclic aromatic hydrocarbon as indicated by the inhibition of gap junctional intercellular communication via phosphatidylcholine-specific phospholipase C.The role of progenitor cells in repair of liver injury and in liver transplantation.Adult stem cell plasticity.Cardiac stem cells.Pediatric liver tumors and hepatic ontogenesis: common and distinctive pathways.Stem cells and the formation of the myocardium in the vertebrate embryo.Adult-derived liver stem cells acquire a cardiomyocyte structural and functional phenotype ex vivo.The epithelial-mesenchymal transition promotes transdifferentiation of subcutaneously implanted hepatic oval cells into mesenchymal tumor tissue.Bone marrow engraftment in a rodent model of chemical carcinogenesis but no role in the histogenesis of hepatocellular carcinomaAdult stem cells and their cardiac potential.Mechanisms controlling the acquisition of a cardiac phenotype by liver stem cells.Impact of selenium supplementation on fish antiviral responses: a whole transcriptomic analysis in rainbow trout (Oncorhynchus mykiss) fed supranutritional levels of Sel-Plex®.Stem cell therapy for the heart.What keeps cells in tissues behaving normally in the face of myriad mutations?Cell-based approaches for cardiac repair.Gene and cell therapy for chronic ischaemic heart disease.Donor cell transplantation for myocardial disease: does it complement current pharmacological therapies?Drugs, gene transfer, signaling factors: a bench to bedside approach to myocardial stem cell therapy.Increased cardiac myocyte progenitors in failing human hearts.Differentiation of adult hepatic stem-like cells into pancreatic endocrine cells.In vivo fluorescence lifetime detection of an activatable probe in infarcted myocardium.Inhibition of gap junctional intercellular communication and activation of mitogen-activated protein kinase by tumor-promoting organic peroxides and protection by resveratrol.Y chromosome detection of three-dimensional tissue-engineered skeletal muscle constructs in a syngeneic rat animal model.Epithelial microchimerism: consistent finding in human liver transplants.Whether modern cell technologies can break down biological limitations of tissue-specific regeneration of the myocardium.The cardiac isoform of α-actin in regenerating and atrophic skeletal muscle, myopathies and rhabdomyomatous tumors: an immunohistochemical study using monoclonal antibodies
P2860
Q28547638-B08689D1-B120-4C92-8F09-BB3C8CDC4910Q33203812-964AC812-4B6B-45B1-8288-1BBF155DD7C4Q33919141-AFB2E88E-D7EB-411F-8D2E-4D1F2CA613AFQ34031221-C4CBDC8F-0977-4E06-9800-989418A256F2Q34124836-41B31F00-2972-475D-A977-5CAF359EB556Q34310259-F907B7AC-0C3C-45CD-B35C-3FF244DDBE80Q34315088-A387CAD4-806D-4DFD-BC4D-46412BE3EACFQ34505307-BC9BA0A3-8AB7-4113-839D-6FCCB522412AQ34565292-483672B1-65C2-40D2-801A-690FB79E6780Q34736836-30547270-31C7-4241-95B7-1E1D55FF8205Q34736853-A8A1A724-A990-44EA-83DE-5EE673132D5FQ34850028-7CB0F3FC-F7F9-4EF5-AA13-F20F975742A6Q34985684-23699302-6679-4ADA-9DA2-C5AECC1EAF55Q35102925-B6564392-98EF-4C7E-878C-160B8E643A0FQ35166167-D738F263-7C2C-4218-94E4-F53073CC5142Q35596591-EE27DE9A-F7BE-4940-9A9A-5DBB774A7581Q35618224-3E791545-A926-4404-ABBF-5B16DD29CDC9Q35651896-B8CBD62D-9AB6-4856-941E-90A8672DF9DFQ35924600-3D925D73-EDA8-4516-811A-553FC0D41C8DQ35980614-DF3D7E81-BB86-42BD-A136-2DDD78F849CDQ36449318-501F0ECF-6E3F-418D-9941-969AED47919CQ36667275-8B8B1823-EBBF-41A5-9708-CA402E36AEE4Q36675432-4ADE3D2C-765C-44FE-947A-DDD98F3AA304Q36814737-0C2BB31A-8117-4A03-9734-FB3D9FE5783CQ36898800-F0E155AB-0C71-4008-803B-F39BD1ABFA94Q37120197-FD90F571-EDAC-4DD8-99AE-207C93258027Q40331889-F0DE3AA2-A7CE-4B6B-AF77-D2C864FBEEF9Q42211008-0BCA6728-36F5-4488-B225-C0067004F6B2Q50694098-6BC4FC92-8F9C-406C-813B-999784B235C3Q51698697-85783C84-07D0-4D4B-9E06-7AEABF0B340FQ51778462-2D7A2F91-38C4-4DB0-A6A2-181D841933C3Q53665716-749D9700-A5FE-49D7-BE29-0D986FDDFD2FQ58438337-5E9CDB47-BF9B-42D2-AB81-5FD5BF75ED43
P2860
Adult-derived stem cells from the liver become myocytes in the heart in vivo.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Adult-derived stem cells from the liver become myocytes in the heart in vivo.
@ast
Adult-derived stem cells from the liver become myocytes in the heart in vivo.
@en
type
label
Adult-derived stem cells from the liver become myocytes in the heart in vivo.
@ast
Adult-derived stem cells from the liver become myocytes in the heart in vivo.
@en
prefLabel
Adult-derived stem cells from the liver become myocytes in the heart in vivo.
@ast
Adult-derived stem cells from the liver become myocytes in the heart in vivo.
@en
P2093
P2860
P1476
Adult-derived stem cells from the liver become myocytes in the heart in vivo.
@en
P2093
J W Grisham
N N Malouf
P A Anderson
R A Lininger
V J Madden
W B Coleman
P2860
P304
P356
10.1016/S0002-9440(10)64661-5
P407
P577
2001-06-01T00:00:00Z